Annual International Primary CNS Lymphoma Collaborative Group Meeting

 描述(申请人提供)：原发性中枢神经系统淋巴瘤(PCNSL)是一种局限于神经系统的非霍奇金淋巴瘤(NHL)的结外变种。PCNSL的诊断和治疗方法不同于适用于其他形式的NHL或其他脑癌的诊断和治疗方法。国际初级中枢神经系统淋巴瘤合作小组(IPCG)由来自多个国家和学科的专家组成，致力于PCNSL的研究。IPCG在美国血液学会会议上举行了一次年度科学会议，会上讨论了与PCNSL有关的各种研究课题。执行委员会每年都会选出一名正在讨论的专题的国际专家来主持科学会议。这些会议产生了多个合作项目，这些项目对该领域产生了积极影响，并已在同行评议文献中发表。IPCG年度会议是一个重要的论坛，可以为这种独特的脑癌和淋巴瘤产生新的想法和方法。2015年会议的主题是复发和难治性原发中枢神经系统淋巴瘤的评估和反应标准，这是一个研究不足的关键话题，因为大多数PCNSL患者对治疗无效或在最初治疗后复发。

 DESCRIPTION (provided by applicant): Primary central nervous system lymphoma (PCNSL) is an extranodal variant of non-Hodgkin lymphoma (NHL) that is confined to the nervous system. The diagnostic and therapeutic approaches to PCNSL are different from those that are applied to other forms of NHL or to other brain cancers. The International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) consists of specialists from multiple countries and disciplines dedicated to the study of PCNSL. The IPCG holds an annual scientific conference at the American Society of Hematology meeting in which various research topics related to PCNSL are discussed. An international expert on the topic under discussion is selected each year by an executive committee to chair the scientific conference. These meetings have led to multiple collaborative projects that have positively impacted the field and that have been published in the peer- reviewed literature. The annual IPCG meeting is a critical forum for generating new ideas and approaches to this unique form of brain cancer and lymphoma. The 2015 conference topic is Evaluation and Response Criteria for Relapsed and Refractory Primary CNS Lymphoma, an understudied and critical topic as most patients with PCNSL are refractory to treatment or subsequently relapse after initial therapy.